If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
885.00    -1.00 (-0.11%)
Bid:
882.00
Ask:
887.00
Spread: 5.00 (0.567%)
Market Cap: £1.23b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Savills Announces Succession Plan

16 Jan 2018 07:00

RNS Number : 9356B
Savills PLC
16 January 2018
 

16 January 2018

SAVILLS PLC

("Savills" or the "Group")

Savills Announces Succession Plan

 

The Board of Savills today announces that Jeremy Helsby will retire as Group Chief Executive at the end of 2018 after a 39 year career at Savills, 11 of them as Group Chief Executive. Jeremy will be succeeded by Mark Ridley, currently CEO of Savills UK and Europe, effective 1 January 2019. Mark will join the Board of Savills plc as Deputy Group Chief Executive on 1 May 2018.

 

Mark Ridley joined Savills in 1996 and brings over 30 years property experience in the UK, European and Asian markets. He was CEO of Savills UK commercial business from May 2008 and has been CEO of Savills UK since January 2013 and additionally of Savills Europe since September 2014. He has also been a member of Savills Group Executive Board since its establishment in February 2008.

 

There are no matters to be disclosed in relation to Mark Ridley under Rule 9.6.13 of the Listing Rules.

 

Nicholas Ferguson, Chairman of Savills plc, comments:

 

"Under Jeremy Helsby's leadership Savills has been transformed into a leading global real estate advisor, tripling revenue and offering the full range of transactional, asset management and consultancy services to clients in the world's prime real estate markets. Jeremy has successfully both internationalised and diversified the business during his decade as Chief Executive.

 

We are all delighted that, following his retirement from the Board at the end of 2018, Jeremy's experience and energy will remain available in an advisory role supporting our US management team in further growing the Savills US business.

 

The Board is delighted to appoint Mark Ridley as Group Chief Executive on Jeremy's retirement from the Board on 31 December 2018. Mark is a highly experienced and respected senior Savills executive who will lead the Group's strong management team through the next phase of the development of the Savills business worldwide. The Board and I very much look forward to working with him as Group Chief Executive."

 

Jeremy Helsby, Group Chief Executive, comments:

 

"I am delighted that Mark will succeed me as Group Chief Executive effective 1 January 2019 and I look forward to working closely with him over the next 12 months to ensure a smooth handover. I am very pleased that from January 2019 I will be able to support Savills in further growing its US business."

 

Mark Ridley, CEO of Savills UK and Europe, comments:

 

"I look forward to working with Jeremy and the rest of the Board over the year ahead as Savills continues to build on its global platform, delivering our clients with the very best service and ensuring we remain the international real estate advisor of choice in key global markets."

 

This announcement contains inside information.

 

For more information, please call:

 

Savills plc 020 7409 8934

Nicholas Ferguson

Chris Lee

 

Tulchan Communications 020 7353 4200

Peter Hewer

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFFDLIIELIT
Date   Source Headline
1st Jul 202611:00 amRNSTotal Voting Rights
19th Jun 20262:28 pmRNSDirector/PDMR Shareholding
18th Jun 202611:37 amRNSDirector/PDMR Shareholding
11th Jun 20263:20 pmRNSDirector/PDMR Shareholding
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.